Copyright Reports & Markets. All rights reserved.

Global Artificial Intelligence Eye Screening Software Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Artificial Intelligence Eye Screening Software by Type
    • 1.3.1 Overview: Global Artificial Intelligence Eye Screening Software Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Artificial Intelligence Eye Screening Software Consumption Value Market Share by Type in 2023
    • 1.3.3 Diabetic Retinopathy (DR)
    • 1.3.4 Age-Related Macular Degeneration (AMD)
    • 1.3.5 Myopia
    • 1.3.6 Others
  • 1.4 Global Artificial Intelligence Eye Screening Software Market by Application
    • 1.4.1 Overview: Global Artificial Intelligence Eye Screening Software Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Medical Institutions
    • 1.4.3 Great Health Scene
  • 1.5 Global Artificial Intelligence Eye Screening Software Market Size & Forecast
  • 1.6 Global Artificial Intelligence Eye Screening Software Market Size and Forecast by Region
    • 1.6.1 Global Artificial Intelligence Eye Screening Software Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Artificial Intelligence Eye Screening Software Market Size by Region, (2019-2030)
    • 1.6.3 North America Artificial Intelligence Eye Screening Software Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Artificial Intelligence Eye Screening Software Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Artificial Intelligence Eye Screening Software Market Size and Prospect (2019-2030)
    • 1.6.6 South America Artificial Intelligence Eye Screening Software Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Artificial Intelligence Eye Screening Software Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Airdoc Technology
    • 2.1.1 Airdoc Technology Details
    • 2.1.2 Airdoc Technology Major Business
    • 2.1.3 Airdoc Technology Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.1.4 Airdoc Technology Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Airdoc Technology Recent Developments and Future Plans
  • 2.2 Digital Diagnostics
    • 2.2.1 Digital Diagnostics Details
    • 2.2.2 Digital Diagnostics Major Business
    • 2.2.3 Digital Diagnostics Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.2.4 Digital Diagnostics Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Digital Diagnostics Recent Developments and Future Plans
  • 2.3 Eyenuk
    • 2.3.1 Eyenuk Details
    • 2.3.2 Eyenuk Major Business
    • 2.3.3 Eyenuk Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.3.4 Eyenuk Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Eyenuk Recent Developments and Future Plans
  • 2.4 RetinaLyze System
    • 2.4.1 RetinaLyze System Details
    • 2.4.2 RetinaLyze System Major Business
    • 2.4.3 RetinaLyze System Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.4.4 RetinaLyze System Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 RetinaLyze System Recent Developments and Future Plans
  • 2.5 Optomed
    • 2.5.1 Optomed Details
    • 2.5.2 Optomed Major Business
    • 2.5.3 Optomed Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.5.4 Optomed Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Optomed Recent Developments and Future Plans
  • 2.6 Sibionics Technology
    • 2.6.1 Sibionics Technology Details
    • 2.6.2 Sibionics Technology Major Business
    • 2.6.3 Sibionics Technology Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.6.4 Sibionics Technology Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Sibionics Technology Recent Developments and Future Plans
  • 2.7 Aeye Health
    • 2.7.1 Aeye Health Details
    • 2.7.2 Aeye Health Major Business
    • 2.7.3 Aeye Health Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.7.4 Aeye Health Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Aeye Health Recent Developments and Future Plans
  • 2.8 VUNO
    • 2.8.1 VUNO Details
    • 2.8.2 VUNO Major Business
    • 2.8.3 VUNO Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.8.4 VUNO Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 VUNO Recent Developments and Future Plans
  • 2.9 Medimaging Integrated Solution
    • 2.9.1 Medimaging Integrated Solution Details
    • 2.9.2 Medimaging Integrated Solution Major Business
    • 2.9.3 Medimaging Integrated Solution Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.9.4 Medimaging Integrated Solution Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Medimaging Integrated Solution Recent Developments and Future Plans
  • 2.10 EyRIS (SELENA+)
    • 2.10.1 EyRIS (SELENA+) Details
    • 2.10.2 EyRIS (SELENA+) Major Business
    • 2.10.3 EyRIS (SELENA+) Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.10.4 EyRIS (SELENA+) Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 EyRIS (SELENA+) Recent Developments and Future Plans
  • 2.11 Vistel
    • 2.11.1 Vistel Details
    • 2.11.2 Vistel Major Business
    • 2.11.3 Vistel Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.11.4 Vistel Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Vistel Recent Developments and Future Plans
  • 2.12 RETINA-AI Health
    • 2.12.1 RETINA-AI Health Details
    • 2.12.2 RETINA-AI Health Major Business
    • 2.12.3 RETINA-AI Health Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.12.4 RETINA-AI Health Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 RETINA-AI Health Recent Developments and Future Plans
  • 2.13 Acer Medical
    • 2.13.1 Acer Medical Details
    • 2.13.2 Acer Medical Major Business
    • 2.13.3 Acer Medical Artificial Intelligence Eye Screening Software Product and Solutions
    • 2.13.4 Acer Medical Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Acer Medical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Artificial Intelligence Eye Screening Software Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Artificial Intelligence Eye Screening Software by Company Revenue
    • 3.2.2 Top 3 Artificial Intelligence Eye Screening Software Players Market Share in 2023
    • 3.2.3 Top 6 Artificial Intelligence Eye Screening Software Players Market Share in 2023
  • 3.3 Artificial Intelligence Eye Screening Software Market: Overall Company Footprint Analysis
    • 3.3.1 Artificial Intelligence Eye Screening Software Market: Region Footprint
    • 3.3.2 Artificial Intelligence Eye Screening Software Market: Company Product Type Footprint
    • 3.3.3 Artificial Intelligence Eye Screening Software Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Artificial Intelligence Eye Screening Software Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Artificial Intelligence Eye Screening Software Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Artificial Intelligence Eye Screening Software Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Artificial Intelligence Eye Screening Software Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Artificial Intelligence Eye Screening Software Consumption Value by Type (2019-2030)
  • 6.2 North America Artificial Intelligence Eye Screening Software Market Size by Application (2019-2030)
  • 6.3 North America Artificial Intelligence Eye Screening Software Market Size by Country
    • 6.3.1 North America Artificial Intelligence Eye Screening Software Consumption Value by Country (2019-2030)
    • 6.3.2 United States Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Artificial Intelligence Eye Screening Software Consumption Value by Type (2019-2030)
  • 7.2 Europe Artificial Intelligence Eye Screening Software Consumption Value by Application (2019-2030)
  • 7.3 Europe Artificial Intelligence Eye Screening Software Market Size by Country
    • 7.3.1 Europe Artificial Intelligence Eye Screening Software Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 7.3.3 France Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Artificial Intelligence Eye Screening Software Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Artificial Intelligence Eye Screening Software Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Artificial Intelligence Eye Screening Software Market Size by Region
    • 8.3.1 Asia-Pacific Artificial Intelligence Eye Screening Software Consumption Value by Region (2019-2030)
    • 8.3.2 China Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 8.3.5 India Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Artificial Intelligence Eye Screening Software Consumption Value by Type (2019-2030)
  • 9.2 South America Artificial Intelligence Eye Screening Software Consumption Value by Application (2019-2030)
  • 9.3 South America Artificial Intelligence Eye Screening Software Market Size by Country
    • 9.3.1 South America Artificial Intelligence Eye Screening Software Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Artificial Intelligence Eye Screening Software Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Artificial Intelligence Eye Screening Software Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Artificial Intelligence Eye Screening Software Market Size by Country
    • 10.3.1 Middle East & Africa Artificial Intelligence Eye Screening Software Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Artificial Intelligence Eye Screening Software Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Artificial Intelligence Eye Screening Software Market Drivers
  • 11.2 Artificial Intelligence Eye Screening Software Market Restraints
  • 11.3 Artificial Intelligence Eye Screening Software Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Artificial Intelligence Eye Screening Software Industry Chain
  • 12.2 Artificial Intelligence Eye Screening Software Upstream Analysis
  • 12.3 Artificial Intelligence Eye Screening Software Midstream Analysis
  • 12.4 Artificial Intelligence Eye Screening Software Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Artificial intelligence (AI) is becoming established as a new method for analysing ophthalmological data, and unveiling new clinical and pathogenic insights into retinal diseases. AI-based algorithms are largely employed in the field of the most prevalent retinal diseases, including diabetic retinopathy, age-related macular degeneration and myopia.
    According to our (Global Info Research) latest study, the global Artificial Intelligence Eye Screening Software market size was valued at US$ 118 million in 2023 and is forecast to a readjusted size of USD 8495 million by 2030 with a CAGR of 82.0% during review period.
    Diabetes continues to rise throughout the United States and worldwide. Estimates show that the prevalence of diabetes mellitus will rise to 578 million people (10.2%) by the year 2030 and 700 million people (10.9%) by the year 2045. This increase in the prevalence of diabetes can also lead to a corresponding increase in diabetic complications, including nephropathy, cardiovascular disease, neuropathy, and retinopathy. It is estimated that vision-threatening diabetic retinopathy (vtDR) is present in around 22% of patients with diabetes, with clinically significant macular edema present in about 4% of patients, although the numbers can widely vary based on the population and access to care. Regardless of the exact numbers, there is no doubt that diabetic retinopathy remains a significant health burden and cause of visual loss. Early detection of diabetic retinopathy is key, because early treatment and lifestyle modifications can help prevent or minimize vision-threatening complications.
    This report is a detailed and comprehensive analysis for global Artificial Intelligence Eye Screening Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Artificial Intelligence Eye Screening Software market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Artificial Intelligence Eye Screening Software market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Artificial Intelligence Eye Screening Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Artificial Intelligence Eye Screening Software market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Artificial Intelligence Eye Screening Software
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Artificial Intelligence Eye Screening Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Artificial Intelligence Eye Screening Software market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Artificial Intelligence Eye Screening Software market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Diabetic Retinopathy (DR)
    Age-Related Macular Degeneration (AMD)
    Myopia
    Others
    Market segment by Application
    Medical Institutions
    Great Health Scene
    Market segment by players, this report covers
    Airdoc Technology
    Digital Diagnostics
    Eyenuk
    RetinaLyze System
    Optomed
    Sibionics Technology
    Aeye Health
    VUNO
    Medimaging Integrated Solution
    EyRIS (SELENA+)
    Vistel
    RETINA-AI Health
    Acer Medical
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Artificial Intelligence Eye Screening Software product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Artificial Intelligence Eye Screening Software, with revenue, gross margin, and global market share of Artificial Intelligence Eye Screening Software from 2019 to 2024.
    Chapter 3, the Artificial Intelligence Eye Screening Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Artificial Intelligence Eye Screening Software market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence Eye Screening Software.
    Chapter 13, to describe Artificial Intelligence Eye Screening Software research findings and conclusion.

    Buy now